Postoperative	postoperative	O	O
myalgia	myalgia	O	S_disease
after	after	O	O
succinylcholine	succinylcholine	S_chemical	O
:	:	O	O
no	no	O	O
evidence	evidence	O	O
for	for	O	O
an	an	O	O
inflammatory	inflammatory	O	O
origin	origin	O	O
.	.	O	O

A	a	O	O
common	common	O	O
side	side	O	O
effect	effect	O	O
associated	associated	O	B_disease
with	with	O	I_disease
succinylcholine	succinylcholine	S_chemical	O
is	is	O	O
postoperative	postoperative	O	O
myalgia	myalgia	O	S_disease
.	.	O	O

The	the	O	O
pathogenesis	pathogenesis	O	O
of	of	O	O
this	this	O	O
myalgia	myalgia	O	S_disease
is	is	O	O
still	still	O	O
unclear	unclear	O	O
;	;	O	O
inflammation	inflammation	O	S_disease
has	has	O	O
been	been	O	O
suggested	suggested	O	O
but	but	O	O
without	without	O	O
convincing	convincing	O	O
evidence	evidence	O	O
.	.	O	O

We	we	O	O
designed	designed	O	O
the	the	O	O
present	present	O	O
study	study	O	O
to	to	O	O
investigate	investigate	O	O
whether	whether	O	O
an	an	O	O
inflammatory	inflammatory	O	O
reaction	reaction	O	O
contributes	contributes	O	O
to	to	O	O
this	this	O	O
myalgia	myalgia	O	S_disease
.	.	O	O

The	the	O	O
incidence	incidence	O	O
and	and	O	O
severity	severity	O	O
of	of	O	O
succinylcholine-associated	succinylcholine-associated	O	O
myalgia	myalgia	O	S_disease
was	was	O	O
determined	determined	O	O
in	in	O	O
64	64	O	O
patients	patients	O	O
pretreated	pretreated	O	O
with	with	O	O
saline	saline	O	O
or	or	O	O
dexamethasone	dexamethasone	S_chemical	O
before	before	O	O
succinylcholine	succinylcholine	S_chemical	O
(	(	O	O
n	n	O	O
=	=	O	O
32	32	O	O
for	for	O	O
each	each	O	O
)	)	O	O
.	.	O	O

Incidence	incidence	O	O
and	and	O	O
severity	severity	O	O
of	of	O	O
myalgia	myalgia	O	S_disease
did	did	O	O
not	not	O	O
differ	differ	O	O
significantly	significantly	O	O
between	between	O	O
the	the	O	O
two	two	O	O
groups	groups	O	O
:	:	O	O
15	15	O	O
patients	patients	O	O
in	in	O	O
the	the	O	O
dexamethasone	dexamethasone	S_chemical	O
group	group	O	O
complained	complained	O	O
of	of	O	O
myalgia	myalgia	O	S_disease
compared	compared	O	O
with	with	O	O
18	18	O	O
patients	patients	O	O
in	in	O	O
the	the	O	O
saline	saline	O	O
group	group	O	O
,	,	O	O
and	and	O	O
severe	severe	O	O
myalgia	myalgia	O	S_disease
was	was	O	O
reported	reported	O	O
by	by	O	O
five	five	O	O
patients	patients	O	O
and	and	O	O
three	three	O	O
patients	patients	O	O
,	,	O	O
respectively	respectively	O	O
(	(	O	O
not	not	O	O
significant	significant	O	O
)	)	O	O
.	.	O	O

At	at	O	O
48	48	O	O
h	h	S_chemical	O
after	after	O	O
surgery	surgery	O	O
,	,	O	O
12	12	O	O
patients	patients	O	O
in	in	O	O
both	both	O	O
groups	groups	O	O
still	still	O	O
suffered	suffered	O	O
from	from	O	O
myalgia	myalgia	O	S_disease
(	(	O	O
not	not	O	O
significant	significant	O	O
)	)	O	O
.	.	O	O

In	in	O	O
addition	addition	O	O
,	,	O	O
interleukin-6	interleukin-6	S_chemical	O
(	(	O	O
IL-6	il-6	O	O
)	)	O	O
as	as	O	O
an	an	O	O
early	early	O	O
marker	marker	O	O
of	of	O	O
inflammation	inflammation	O	S_disease
was	was	O	O
assessed	assessed	O	O
in	in	O	O
a	a	O	O
subgroup	subgroup	O	O
of	of	O	O
10	10	O	O
patients	patients	O	O
pretreated	pretreated	O	O
with	with	O	O
saline	saline	O	O
.	.	O	O

We	we	O	O
found	found	O	O
an	an	O	O
increase	increase	O	O
of	of	O	O
IL-6	il-6	O	O
for	for	O	O
only	only	O	O
three	three	O	O
patients	patients	O	O
,	,	O	O
but	but	O	O
only	only	O	O
one	one	O	O
patient	patient	O	O
reported	reported	O	O
myalgia	myalgia	O	S_disease
;	;	O	O
no	no	O	O
relationship	relationship	O	O
between	between	O	O
myalgia	myalgia	O	S_disease
and	and	O	O
the	the	O	O
increase	increase	O	O
of	of	O	O
IL-6	il-6	O	O
was	was	O	O
found	found	O	O
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
there	there	O	O
is	is	O	O
no	no	O	O
evidence	evidence	O	O
for	for	O	O
an	an	O	O
inflammatory	inflammatory	O	O
origin	origin	O	O
of	of	O	O
succinylcholine-associated	succinylcholine-associated	O	O
myalgia	myalgia	O	S_disease
.	.	O	O

IMPLICATIONS	implications	O	O
:	:	O	O
Administration	administration	O	O
of	of	O	O
dexamethasone	dexamethasone	S_chemical	O
before	before	O	O
succinylcholine	succinylcholine	S_chemical	O
was	was	O	O
not	not	O	O
effective	effective	O	O
in	in	O	O
decreasing	decreasing	O	O
the	the	O	O
incidence	incidence	O	O
or	or	O	O
the	the	O	O
severity	severity	O	O
of	of	O	O
succinylcholine-induced	succinylcholine-induced	O	O
postoperative	postoperative	O	O
myalgia	myalgia	O	S_disease
.	.	O	O

Furthermore	furthermore	O	O
,	,	O	O
there	there	O	O
was	was	O	O
no	no	O	O
significant	significant	O	O
relationship	relationship	O	O
between	between	O	O
postoperative	postoperative	O	O
myalgia	myalgia	O	S_disease
and	and	O	O
time	time	O	O
course	course	O	O
of	of	O	O
interleukin-6	interleukin-6	S_chemical	O
concentrations	concentrations	O	O
,	,	O	O
a	a	O	O
marker	marker	O	O
of	of	O	O
inflammation	inflammation	O	S_disease
.	.	O	O

Pretreatment	pretreatment	O	O
with	with	O	O
dexamethasone	dexamethasone	S_chemical	O
is	is	O	O
not	not	O	O
justified	justified	O	O
to	to	O	O
prevent	prevent	O	O
postoperative	postoperative	O	O
myalgia	myalgia	O	S_disease
after	after	O	O
succinylcholine	succinylcholine	S_chemical	O
.	.	O	O

